About Targos
Targos is a company based in Kassel (Germany) founded in 2005 by Thomas Henkel was acquired by Discovery Life Sciences in May 2021. Targos operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others.
- Headquarter Kassel, Germany
- Founders Thomas Henkel
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website targos-gmbh.de
- Acquired by Discovery Life Sciences (May 2021)
- Investors
- Acquired byDiscovery Life Sciences
(May 2021)
Investors in Targos
Targos has secured backing from 1 investor. Prominent investors backing the company include Discovery Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of diversified services with integrated technology platforms for drug discovery | 2006 | dls.com | Huntsville, United States |
Investor details for Targos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Targos
1 people are tracked at Targos (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Henkel | Co-Founder & CEO | Leadership |
Complete people profiles for Targos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Targos
2 dated milestones of Targos across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Targos is founded.
- Exit Acquired by Discovery Life Sciences.
Competitors of Targos
Targos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits | |
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| omasstech.com | 2016 | Oxford, United Kingdom | $19.32M | 39 | Native mass spectrometry services for protein characterization are provided. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| phylos.bio | 2014 | Portland, United States | $28.41M | 61 | Developer of cannabis breeding tools for agriculture & other health purposes | |
| afyren.com | 2012 | Paris, France | $25.59M | – | Analytical services are provided for microbiology, chemistry, and bioprocesses sectors. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. |
Detailed competitors of Targos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Targos
Complete news archive for Targos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Targos
10 companies that operate in the same segment as Targos (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Targos
Targos was founded in 2005.
Targos is headquartered in Kassel, Germany. It is registered at Kassel, Hesse, Germany.
Thomas Henkel is the current CEO of Targos. They have also founded this company.
Targos is an FDA-inspected, GCP-compliant, CAP accredited, CLIA-enrolled central laboratory offering biomarker analysis and biomarker development services mainly for clinical trials. They claim to have analysed samples of more than 60,000 patients, in100 clinical trials pertaining to breast, gastric, lung and skin cancers in more than 1000 sites worldwide, since their inception. The company has a biomarker service portfolio catering to 44 biomarkers. Their laboratories are capable of analysing biomarkers through a portfolio of techniques including IHC, ISH, mutation analysis, parallel sequencing, ELISA andor digital pathology and others. The company has board certified pathologists who coordinate clinical trials. Targos also offers clinical trial services such as project, data and quality management and logistics. The company also offer services for the development of companion diagnostics (CDx) and had supported the first development of CDx for Roche COBAS and B-RAF along with the GenentechRoche drug Zelboraf in a prospective clinical trial.
Targos's top competitors include PathogenDX, Alderley Analytical and BioAgilytix.
Targos has 1 investor. Key investors include Discovery Life Sciences.
Yes. Targos was acquired by Discovery Life Sciences in May 2021.